Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 5, 2008, Pages 747-757

  Miyazaki, Akiko ^a,b   Kitaichi, Nobuyoshi ^a   Ohgami, Kazuhiro ^a   Iwata, Daiju ^a   Jin, Xue Hai ^a   Iwabuchi, Kazuya ^b   Morohashi, Taiki ^c   Ohno, Shigeaki ^a   Onoé, Kazunori ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Omori Red Cross Hospital   (Japan)

Author keywords

AT1; EAU; EIU; Losartan; NF B; RAS; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ENDOTOXIN; FREUND ADJUVANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; LIPOPOLYSACCHARIDE; LOSARTAN POTASSIUM; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PERTUSSIS TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; AQUEOUS HUMOR; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; C57BL 6 MOUSE; CELL COUNT; CELL INFILTRATION; CHEMOPROPHYLAXIS; CILIARY BODY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; EYE INFLAMMATION; FEMALE; IMMUNOHISTOCHEMISTRY; IRIS; LEWIS RAT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK REDUCTION; SCORING SYSTEM; T LYMPHOCYTE; UVEITIS; UVEORETINITIS;

ACUTE DISEASE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AQUEOUS HUMOR; AUTOIMMUNE DISEASES; CHEMOKINE CCL2; CILIARY BODY; DISEASE MODELS, ANIMAL; FEMALE; LIPOPOLYSACCHARIDES; LOSARTAN; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; RENIN-ANGIOTENSIN SYSTEM; RETINITIS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 42049120493     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0730-2     Document Type: Article

References (52)

1. Amuchastegui SC, Azzollini N, Mister M, Pezzotta A, Perico N, Remuzzi G (1998) Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 9:1948-1955
2. Andersson P, Cederholm T, Johansson AS, Palmblad J (2002) Captopril-impaired production of tumor necrosis factor-α-induced interleukin-1β in human monocytes is associated with altered intracellular distribution of nuclear factor-κB. J Lab Clin Med 140:103-109
3. Baldwin AS Jr (1996) The NF-κB and I κB proteins: New discoveries and insights. Annu Rev Immunol 14:649-683
4. Barnes PJ (1997) Nuclear factor-κB. Int J Biochem Cell Biol 29:867-870
5. Barnes PJ, Karin M (1997) Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
6. Benediktsson H, Chea R, Davidoff A, Paul LC (1996) Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation 62:1634-1642
7. Caspi RR, Roberge FG, McAllister CG, el-Saied M, Kuwabara T, Gery I, Hanna E, Nussenblatt RB (1986) T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 136:928-933
8. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140:1490-1495
9. Chan CC, Tuaillon N, Li Q, Shen DF (2000) Therapeutic applications of antiflammin peptides in experimental ocular inflammation. Ann N Y Acad Sci 923:141-146
10. Chiu AT, Dunscomb J, Kosierowski J, Burton CR, Santomenna LD, Corjay MH, Benfield P (1993) The ligand binding signatures of the rat AT1A, AT1B and the human AT1 receptors are essentially identical. Biochem Biophys Res Commun 197:440-449
11. Chua CC, Hamdy RC, Chua BH (1998) Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1401:187-194
12. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
13. de Vos AF, van Haren MA, Verhagen C, Hoekzema R, Kijlstra A (1994) Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Investig Ophthalmol Vis Sci 35:1100-1106
14. Fukuzawa M, Satoh J, Sagara M, Muto G, Muto Y, Nishimura S, Miyaguchi S, Qiang XL, Sakata Y, Nakazawa T, Ikehata F, Ohta S, Toyota T (1997) Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo. Immunopharmacology 36:49-55
15. Furukawa Y, Matsumori A, Hirozane T, Sasayama S (1996) Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 93:333-339
16. Godsel LM, Leon JS, Engman DM (2003a) Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des 9:723-735
17. Godsel LM, Leon JS, Wang K, Fornek JL, Molteni A, Engman DM (2003b) Captopril prevents experimental autoimmune myocarditis. J Immunol 171:346-352
18. Gregerson DS, Obritsch WF, Fling SP, Cameron JD (1986) S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis. J Immunol 136:2875-2882
19. Gu L, Tseng SC, Rollins BJ (1999) Monocyte chemoattractant protein-1. Chem Immunol 72:7-29
20. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Murakami K (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627-635
21. Ilieva I, Ohgami K, Jin XH, Suzuki Y, Shiratori K, Yoshida K, Kase S, Ohno S (2006) Captopril suppresses inflammation in endotoxin-induced uveitis in rats. Exp Eye Res 83:651-657
22. Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S (2005) Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 54:349-356
23. Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, Kitamura M, Ohno S, Onoé K (2006) Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-κB (NF-κB), pyrrolidine dithiocarbamate. J Leukoc Biol 79:1193-1201
24. Kramer C, Sunkomat J, Witte J, Luchtefeld M, Walden M, Schmidt B, Tsikas D, Boger RH, Forssmann WG, Drexler H, Schieffer B (2002) Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: Role of the active metabolite EXP3179. Circ Res 90:770-776
25. Kranzhofer R, Browatzki M, Schmidt J, Kubler W (1999) Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes. Biochem Biophys Res Commun 257:826-828
26. Kurihara T, Ozawa Y, Shinoda K, Nagai N, Inoue M, Oike Y, Tsubota K, Ishida S, Okano H (2006) Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Investig Ophthalmol Vis Sci 47:5545-5552
27. Levens NR (1984) Modulation of jejunal ion and water absorption by endogenous angiotensin after dehydration. Am J Physiol 246:G700-G709
28. Li Q, Peng B, Whitcup SM, Jang SU, Chan CC (1995) Endotoxin induced uveitis in the mouse: Susceptibility and genetic control. Exp Eye Res 61:629-632
29. Miyoshi M, Nagata K, Imoto T, Goto O, Ishida A, Watanabe T (2003) ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats. Am J Physiol Regul Integr Comp Physiol 284:R1092-R1097
30. Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I (1985) Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Investig Ophthalmol Vis Sci 26:1-9
31. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233-236
32. Nagai N, Oike Y, Noda K, Urano T, Kubota Y, Ozawa Y, Shinoda H, Koto T, Shinoda K, Inoue M, Tsubota K, Yamashiro K, Suda T, Ishida S (2005) Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Investig Ophthalmol Vis Sci 46:2925-2931
33. Peeters AC, Netea MG, Kullberg BJ, Thien T, van der Meer JW (1998) The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 94:376-379
34. Planck SR, Huang XN, Robertson JE, Rosenbaum JT (1994) Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Investig Ophthalmol Vis Sci 35:924-930
35. Price A, Lockhart JC, Ferrell WR, Gsell W, McLean S, Sturrock RD (2007) Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis. Arthritis Rheum 56:441-447
36. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR (1980) Endotoxin-induced uveitis in rats as a model for human disease. Nature 286:611-613
37. Rossig L, Dimmeler S, Zeiher AM (2001) Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol 96:11-22
38. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J (1998) Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161:430-439
39. Sadoshima J (2002) Novel AT(1) receptor-independent functions of losartan. Circ Res 90:754-756
40. Sandberg K (1994) Structural analysis and regulation of angiotensin II receptors. TEM 5:28-35
41. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ (1992) Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 185:253-259
42. Shimizu H, Miyoshi M, Matsumoto K, Goto O, Imoto T, Watanabe T (2004) The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1β response in rats. J Pharmacol Exp Ther 308:865-873
43. Tanaka A, Matsumori A, Wang W, Sasayama S (1994) An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation 90:2051-2055
44. Taylor AW, Yee DG, Nishida T, Namba K (2000) Neuropeptide regulation of immunity. The immunosuppressive activity of α-melanocyte-stimulating hormone (α-MSH). Ann NY Acad Sci 917:239-247
45. Tegeder I, Pfeilschifter J, Geisslinger G (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb J 15:2057-2072
46. Timmermans PB, Smith RD (1994) Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 15(Suppl D):79-87
47. Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC (2002) MCP-1 expression in endotoxin-induced uveitis. Investig Ophthalmol Vis Sci 43:1493-1498
48. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T (1994) NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153:2052-2063
49. Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D (1997) Chemokines in acute anterior uveitis. Curr Eye Res 16:1202-1208
50. Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC (2000) Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-κB dependent. Kidney Int 57:2011-2022
51. Wesselman JP, De Mey JG (2002) Angiotensin and cytoskeletal proteins: role in vascular remodeling. Curr Hypertens Rep 4:63-70
52. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F (2002) Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors. Kidney Int 61:1986-1995